Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: J Immunol. 2011 Jun 20;187(2):861–869. doi: 10.4049/jimmunol.1004009

Figure 4. SFZ70.Rag1−/− T cells display an activated phenotype.

Figure 4

(A) Incorporation of BrdU by CD4+ lymphocytes from the skin-draining LN of SFZ70.Rag1−/−, OT-II.Rag1−/−or WT mice. Graph indicates the percent BrdU+ cells amongst Foxp3+ or Foxp3− cells from each group. (B) Expression of CD44, CD103, and P-selectin ligand (P-lig) by CD4+ lymphocytes isolated from the skin draining LN of SFZ70.Rag1−/−, OT-II.Rag1−/− or WT mice. Statistical significance was determined using a one-way repeated-measures analysis of variance; a Tukey post-test was used to obtain the p-value for the bracketed pairwise comparison. **, P < 0.01; ***, P < 0.001. Data are representative of three independent experiments with 3–5 mice per group.